MY140890A - New tiotropium containing powder formulation for inhalation - Google Patents

New tiotropium containing powder formulation for inhalation

Info

Publication number
MY140890A
MY140890A MYPI20034544A MYPI20034544A MY140890A MY 140890 A MY140890 A MY 140890A MY PI20034544 A MYPI20034544 A MY PI20034544A MY PI20034544 A MYPI20034544 A MY PI20034544A MY 140890 A MY140890 A MY 140890A
Authority
MY
Malaysia
Prior art keywords
inhalation
powder formulation
containing powder
new tiotropium
tiotropium containing
Prior art date
Application number
MYPI20034544A
Inventor
Mareke Dr Hartig
Michael Dr Trunk
Michael Dr Walz
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32308760&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MY140890(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of MY140890A publication Critical patent/MY140890A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0021—Mouthpieces therefor
    • A61M15/0025—Mouthpieces therefor with caps
    • A61M15/0026—Hinged caps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0033—Details of the piercing or cutting means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

THE INVENTION RELATES TO POWDERED PREPARATIONS CONTAINING TIOTROPIUM FOR INHALATION, PROCESSES FOR PREPARING THEM AS WELL AS THEIR USE IN PREPARING A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF RESPIRATORY COMPLAINTS, PARTICULARLY FOR THE TREATMENT OF COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE) AND ASTHMA.
MYPI20034544A 2002-11-28 2003-11-27 New tiotropium containing powder formulation for inhalation MY140890A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10255387A DE10255387A1 (en) 2002-11-28 2002-11-28 New tiotropium-containing powder formulation for inhalation

Publications (1)

Publication Number Publication Date
MY140890A true MY140890A (en) 2010-01-29

Family

ID=32308760

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20034544A MY140890A (en) 2002-11-28 2003-11-27 New tiotropium containing powder formulation for inhalation

Country Status (33)

Country Link
EP (1) EP1567135B1 (en)
JP (1) JP4977321B2 (en)
KR (1) KR101066805B1 (en)
CN (1) CN100574751C (en)
AR (1) AR042242A1 (en)
AT (1) ATE401861T1 (en)
AU (1) AU2003294714B2 (en)
BR (1) BR0316343A (en)
CA (1) CA2507579C (en)
CO (1) CO5580736A2 (en)
CY (1) CY1108420T1 (en)
DE (2) DE10255387A1 (en)
DK (1) DK1567135T3 (en)
EA (1) EA011549B1 (en)
EC (1) ECSP055821A (en)
ES (1) ES2310681T3 (en)
HR (1) HRP20050468A2 (en)
IL (1) IL168810A (en)
ME (1) MEP51608A (en)
MX (1) MXPA05005485A (en)
MY (1) MY140890A (en)
NO (1) NO20053090L (en)
PE (1) PE20040848A1 (en)
PL (1) PL376229A1 (en)
PT (1) PT1567135E (en)
RS (1) RS20050400A (en)
SA (1) SA04240467B1 (en)
SI (1) SI1567135T1 (en)
TW (1) TWI332837B (en)
UA (1) UA81930C2 (en)
UY (1) UY28096A1 (en)
WO (1) WO2004047796A2 (en)
ZA (1) ZA200502859B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006016904A1 (en) 2006-04-11 2007-10-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg inhaler
DE102008014025A1 (en) * 2008-03-13 2009-09-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhaler and strainer for an inhaler
TR200909788A2 (en) 2009-12-25 2011-07-21 Bi̇lgi̇ç Mahmut Dry powder formulation suitable for inhalation with tiotropium
EA024922B1 (en) * 2010-08-03 2016-11-30 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Dry powder formulation comprising a phosphodiesterase inhibitor
BR112015010601B1 (en) * 2012-11-09 2022-07-19 Civitas Therapeutics, Inc. PHARMACEUTICAL COMPOSITION AND USE OF THE COMPOSITION
KR101748796B1 (en) * 2015-09-30 2017-06-19 한미약품 주식회사 Inhalation capsule with enhanced delivery rate of active ingredients
KR101728116B1 (en) * 2015-11-03 2017-04-18 한미약품 주식회사 Dry powder composition for inhalation comprising tiotropium or pharmaceutically acceptable salt thereof
CN111514418B (en) * 2019-06-12 2022-01-14 中南大学湘雅二医院 Self-suction nasal powder material feeding device

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3957965A (en) * 1967-08-08 1976-05-18 Fisons Limited Sodium chromoglycate inhalation medicament
GB1242211A (en) * 1967-08-08 1971-08-11 Fisons Pharmaceuticals Ltd Pharmaceutical composition
DE4140689B4 (en) * 1991-12-10 2007-11-22 Boehringer Ingelheim Kg Inhalable powders and process for their preparation
DE4318455A1 (en) * 1993-06-03 1994-12-08 Boehringer Ingelheim Kg Capsule holder
GB9322014D0 (en) * 1993-10-26 1993-12-15 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
DE4425255A1 (en) * 1994-07-16 1996-01-18 Asta Medica Ag Formulation for inhalation application
CN1150895C (en) * 1998-11-13 2004-05-26 杰格研究股份公司 Dry powder for administration by inhalation
GB9902689D0 (en) * 1999-02-08 1999-03-31 Novartis Ag Organic compounds
AP1712A (en) * 2000-10-12 2007-01-24 Boehringer Ingelheim Pharma Novel tiotropium-containing inhalation powder
UA75375C2 (en) * 2000-10-12 2006-04-17 Boehringer Ingelheim Pharma Method for producing powdery preparations for inhaling
DE10126924A1 (en) * 2001-06-01 2002-12-05 Boehringer Ingelheim Pharma Inhalation capsule contains powdered mixture of tiotropium and auxiliary, for treating asthma or chronic obstructive pulmonary disease, having capsule material of low moisture content to improve stability
DE10141377A1 (en) * 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Scattering process for the production of powder formulations
WO2003084509A1 (en) * 2002-04-04 2003-10-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Powder formulations suitable for inhalation
UA80123C2 (en) * 2002-04-09 2007-08-27 Boehringer Ingelheim Pharma Inhalation kit comprising inhalable powder of tiotropium

Also Published As

Publication number Publication date
NO20053090D0 (en) 2005-06-23
WO2004047796A3 (en) 2004-09-30
CA2507579A1 (en) 2004-06-10
ECSP055821A (en) 2005-08-11
MXPA05005485A (en) 2005-07-25
SA04240467B1 (en) 2008-10-15
MEP51608A (en) 2011-02-10
CN1717225A (en) 2006-01-04
ATE401861T1 (en) 2008-08-15
JP2006510622A (en) 2006-03-30
EP1567135B1 (en) 2008-07-23
CN100574751C (en) 2009-12-30
TWI332837B (en) 2010-11-11
KR20050086887A (en) 2005-08-30
HK1085918A1 (en) 2006-09-08
AU2003294714A1 (en) 2004-06-18
AR042242A1 (en) 2005-06-15
PE20040848A1 (en) 2005-01-14
UA81930C2 (en) 2008-02-25
CO5580736A2 (en) 2005-11-30
DK1567135T3 (en) 2008-10-27
ES2310681T3 (en) 2009-01-16
EP1567135A2 (en) 2005-08-31
RS20050400A (en) 2007-04-10
EA200500864A1 (en) 2006-02-24
PT1567135E (en) 2008-09-01
DE50310208D1 (en) 2008-09-04
TW200500066A (en) 2005-01-01
AU2003294714B2 (en) 2009-10-08
CA2507579C (en) 2011-07-19
HRP20050468A2 (en) 2006-07-31
PL376229A1 (en) 2005-12-27
IL168810A (en) 2015-02-26
DE10255387A1 (en) 2004-06-09
JP4977321B2 (en) 2012-07-18
UY28096A1 (en) 2004-06-30
CY1108420T1 (en) 2014-04-09
SI1567135T1 (en) 2008-10-31
NO20053090L (en) 2005-06-23
WO2004047796A2 (en) 2004-06-10
BR0316343A (en) 2005-09-27
EA011549B1 (en) 2009-04-28
ZA200502859B (en) 2006-02-22
KR101066805B1 (en) 2011-09-22

Similar Documents

Publication Publication Date Title
MY123544A (en) New inhalable powder containing tiotropium
MY155912A (en) New inhalable powder containing tiotropium
UA83813C2 (en) Powdered medicament for inhalation comprising a tiotropium salt and salmeterol xinafoate
MY153151A (en) Inhalation kit comprising inhalable powder of tiotropium
MY143517A (en) Formoterol superfine formulation
HK1203149A1 (en) Novel dosage form and formulation of abediterol
ATE276000T1 (en) POWDER INHALER FOR A COMBINED MEDICATION
CA2550841A1 (en) Novel combination of anticholinergic and .beta. mimetics for the treatment of respiratory diseases
UA101652C2 (en) Composition for inhalation comprising aclidinium for the treatment of asthma and chronic obstructive pulmonary disease
MY145166A (en) Novel tiotropium salts, process for the preparation and pharmaceutical compositions thereof
CY1108420T1 (en) STANDARD TYPOTROPIC POWDER FOR INHALATION
MY143364A (en) Method for producing tiotropium salts
IL163736A0 (en) Powder formulations suitable for inhalation
WO2005007134A8 (en) Powdery formulations for inhalation, containing a novel anticholinergic agent
AU2009224894A8 (en) Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease